| Patient | Sun Yat-sen |
|---|---|
| Date of birth | 1866-11-12 |
| Identifiers | MRN HR-ET016-SYN-TD; SSN (made up) 000-16-4183 |
| Document date | 1924-09-02 |
| Author | Wen-Li Huang, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Sore throat, runny nose and cough for three days during chemotherapy. [S]
Mr. Sun called the clinic and was seen the same day. Three days ago he developed a scratchy throat and a runny nose after a week of meetings, and since yesterday a dry cough. He checked his temperature twice a day as taught and the highest was 37.5 °C; he has had no shivering. He is on day 10 of cycle 5 of gemcitabine, cisplatin and durvalumab and had his day-8 infusion two days ago. He is not short of breath, even on the stairs, and has no chest pain, diarrhea, rash, or new abdominal pain. His appetite is a little lower but he is drinking well. Two colleagues at work have colds. He asked whether this could be pneumonitis from durvalumab and whether he needs antibiotics. [S]
| Element | Detail |
|---|---|
| Onset | Three days ago, after colleagues at work had colds |
| Symptoms | Sore throat, runny nose, dry cough |
| Temperature | Highest 37.5 °C at home; no shivering |
| Treatment context | Day 10 of cycle 5 of gemcitabine, cisplatin and durvalumab; day-8 dose two days ago |
| Associated signs and symptoms | No breathlessness, chest pain, diarrhea, rash, or new abdominal pain |
| Modifying factors | Warm drinks and honey help the throat |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; no fever above 37.5 °C; no shivering |
| Ears, nose, mouth, and throat | Positive | Sore throat and runny nose; no mouth ulcers |
| Respiratory | Positive | Dry cough; no breathlessness or sputum |
| Cardiovascular | Negative | No chest pain or palpitations |
| Gastrointestinal | Negative | No diarrhea, vomiting, or new abdominal pain |
| Integumentary | Negative | No rash; port site not sore |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, two tablets by mouth every 8 hours as needed for right upper abdominal ache; no more than 3,000 mg a day | Two tablets by mouth every 8 hours as needed, no more than 3,000 mg a day | Oral route | 1924-05-04 | active | S |
| Gemcitabine 1,000 mg/m2 (1,660 mg) intravenous infusion on days 1 and 8 of each 21-day cycle | Days 1 and 8 of each 21-day cycle, up to 8 cycles | Intravenous route | 1924-06-01 | active | S |
| Cisplatin 25 mg/m2 (41 mg) intravenous infusion on days 1 and 8 of each 21-day cycle | Days 1 and 8 of each 21-day cycle, up to 8 cycles, with hydration | Intravenous route | 1924-06-01 | active | S |
| Durvalumab 1,500 mg intravenous infusion on day 1 of each 21-day cycle | Day 1 of each 21-day cycle with chemotherapy, then every 4 weeks alone | Intravenous route | 1924-06-01 | active | S |
| Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nausea | One tablet by mouth every 8 hours as needed for nausea | Oral route | 1924-06-01 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1924-09-02 | Body height | 165 | cm | S |
| 1924-09-02 | Body weight | 59 | kg | S |
| 1924-09-02 | Body mass index (BMI) [Ratio] | 21.7 | kg/m2 | S |
| 1924-09-02 | Systolic blood pressure | 120 | mm[Hg] | S |
| 1924-09-02 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 1924-09-02 | Heart rate | 90 | /min | S |
| 1924-09-02 | Respiratory rate | 16 | /min | S |
| 1924-09-02 | Body temperature | 37.4 | Cel | S |
| 1924-09-02 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1924-09-02 | Leukocytes [#/volume] in Blood by Automated count | 3.9 | 10*3/uL | 4-11 10*3/uL | Low | S |
| 1924-09-02 | Neutrophils [#/volume] in Blood by Automated count | 1.6 | 10*3/uL | 1.8-7.7 10*3/uL | Low | S |
| 1924-09-02 | Hemoglobin [Mass/volume] in Blood | 10.6 | g/dL | 13.2-17.1 g/dL | Low | S |
| 1924-09-02 | Platelets [#/volume] in Blood by Automated count | 162 | 10*3/uL | 150-400 10*3/uL | Normal | S |
Vital signs recorded on 1924-09-02; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Tired but well; temperature 37.4 °C, pulse 90, blood pressure 120/76, oxygen saturation 97% on room air, respirations 16 |
| Ears, nose, mouth, and throat | Red throat without exudate; no mouth ulcers or thrush; clear nasal discharge |
| Neck | No tender or enlarged lymph nodes |
| Respiratory | Clear to auscultation bilaterally; no crackles or wheeze; oxygen saturation stays at 97% after walking the corridor |
| Skin | Port site clean, without redness or tenderness; no rash |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Right upper quadrant abdominal mass with weight loss: a dull ache under the right ribs and early fullness for about three months, 4 kg weight loss, and a firm, non-tender mass felt 4 cm below the right costal margin; no jaundice, fever, or itching. Ultrasound today: a 6.8 cm solid, heterogeneous mass in liver segments IV and V that cannot be separated from the gallbladder, which contains stones; the rest of the liver is smooth, with no ascites. Multiphase CT, tumor markers, hepatitis serology and medical oncology consultation arranged | resolved | confirmed | R19.01 | S — Synthetic presenting problem anchored to the documented right upper abdominal mass; superseded by the biopsy diagnosis. |
| Adenocarcinoma of the gallbladder invading the liver: core biopsy of the liver mass shows moderately differentiated adenocarcinoma (CK7 positive, CK20 and CDX2 negative), and multiphase CT and MRI show a 7.1 cm mass arising from the gallbladder fundus and invading liver segments IVb and V, with gallstones and two enlarged nodes in the hepatoduodenal ligament; no cirrhosis; alpha-fetoprotein normal, CA 19-9 raised. Clinical T3 N1 before staging laparoscopy (AJCC 8th edition). Synthetic modern episode linked to his documented final illness, described in life as liver cancer and at autopsy as gallbladder adenocarcinoma | active | confirmed | C23 | S — Synthetic modern diagnosis chosen to fit the documented findings: a mass involving the liver at operation and gallbladder adenocarcinoma at autopsy. |
| Resolved hepatitis B infection: hepatitis B surface antigen negative, total core antibody positive, surface antibody positive, HBV DNA undetectable; hepatitis C antibody negative. At risk of reactivation during chemotherapy and immunotherapy; monitored | active | confirmed | Z86.19 | S — Synthetic serology; not a claim that he had hepatitis B in his lifetime. No fetched source mentions hepatitis. |
| Peritoneal metastases from gallbladder adenocarcinoma: several 3 to 6 mm nodules on the parietal peritoneum and omentum at staging laparoscopy, biopsy positive for adenocarcinoma of the same type; stage IVB (M1), not resectable | active | confirmed | C78.6 | S — Synthetic finding anchored to the peritoneal metastases reported at autopsy. |
| Acute viral upper respiratory infection on day 10 of cycle 5 of chemoimmunotherapy: sore throat, runny nose and dry cough for three days, afebrile, with a neutrophil count of 1.6 x10^3/uL; rapid tests for SARS-CoV-2 and influenza negative; no sign of pneumonia or pneumonitis; resolved | active | confirmed | J06.9 | S — Synthetic acute illness; not a historical claim. |
Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Biliary Tract Cancers (2026); Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update (2021); Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update (2018)
Follow-up: Phone check in two days. Cycle 6 day 1 as booked, with the oncology team; preventive visit in about three weeks. Next scheduled visit 1924-09-21: periodic adult preventive visit. [S]